These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29204953)

  • 1. Comparing Safety and Efficacy of "Third-Generation" Antiepileptic Drugs: Long-Term Extension and Post-marketing Treatment.
    Kwok CS; Johnson EL; Krauss GL
    CNS Drugs; 2017 Nov; 31(11):959-974. PubMed ID: 29204953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
    Brigo F; Bragazzi NL; Nardone R; Trinka E
    Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy.
    Li-Na Z; Deng C; Hai-Jiao W; Da X; Ge T; Ling L
    Epilepsy Res; 2018 Jan; 139():60-72. PubMed ID: 29197667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When adverse effects are seen as desirable: Abuse potential of the newer generation antiepileptic drugs.
    Hawkins KL; Gidal BE
    Epilepsy Behav; 2017 Dec; 77():62-72. PubMed ID: 29111505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.
    Brodie MJ
    CNS Drugs; 2015 Nov; 29(11):893-904. PubMed ID: 26507832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
    Stephen LJ; Wishart A; Brodie MJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
    Chung S; Sinha SR; Shah A; Stern JM; Cheng H; Jung J; Grinnell T; Blum D
    Epilepsy Res; 2019 Jul; 153():59-65. PubMed ID: 30999260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
    Groth A; Wilke T; Borghs S; Gille P; Joeres L
    Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience.
    Gama H; Vieira M; Costa R; Graça J; Magalhães LM; Soares-da-Silva P
    Drug Saf; 2017 Dec; 40(12):1231-1240. PubMed ID: 28752473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third generation antiepileptic drug monotherapies in adults with epilepsy.
    Mula M
    Expert Rev Neurother; 2016 Sep; 16(9):1087-92. PubMed ID: 27248204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiepileptic drugs].
    Herranz JL
    Rev Neurol; 2018 Jun; 66(s02):S21-S25. PubMed ID: 29876908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis.
    Zhuo C; Jiang R; Li G; Shao M; Chen C; Chen G; Tian H; Li J; Xue R; Jiang D
    Sci Rep; 2017 May; 7(1):2535. PubMed ID: 28566726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the longer-term cognitive effects of adjunctive perampanel compared to lacosamide in a naturalistic outpatient setting.
    Meschede C; Witt JA; Rademacher M; von Wrede RD; Elger CE; Helmstaedter C
    Seizure; 2018 May; 58():141-146. PubMed ID: 29704679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.
    Patsalos PN; Berry DJ
    Expert Opin Pharmacother; 2012 Apr; 13(5):699-715. PubMed ID: 22404663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in the management of partial-onset epilepsy: role of brivaracetam.
    Coppola G; Iapadre G; Operto FF; Verrotti A
    Drug Des Devel Ther; 2017; 11():643-657. PubMed ID: 28293101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of generalized tonic-clonic seizures in refractory focal epilepsy: a meta-analysis.
    Hemery C; Ryvlin P; Rheims S
    Epilepsia; 2014 Nov; 55(11):1789-99. PubMed ID: 25182978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies.
    Moseley BD; Sperling MR; Asadi-Pooya AA; Diaz A; Elmouft S; Schiemann J; Whitesides J
    Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
    Kurth C; Kockelmann E; Steinhoff BJ
    Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of adjunct perampanel based on number of antiepileptic drugs at baseline and baseline predictors of efficacy: A phase III post-hoc analysis.
    Glauser T; Laurenza A; Yang H; Williams B; Ma T; Fain R
    Epilepsy Res; 2016 Jan; 119():34-40. PubMed ID: 26656783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.